Abstract
Stereoisomeric dipeptide prodrug approach has overcome the barriers of the conventional drug delivery method. This approach offers a much more efficient release of the drug by becoming active after the drug is inside the body. Acyclovir (ACV) drug is mostly used to treat herpes, and it was modified by addition of stereospecific dipeptides, L-valine and D-valine, resulting in L-valine-D-valine-acyclovir. This prodrug disintegrates into the parent drug ACV inside the body. This chapter discusses the synthesis method of such drugs along with the types of diseases that could be treated. Moreover, various drug delivery methods are also mentioned, which further encapsulate these stereoisomeric dipeptide prodrugs like nanoparticles and solid lipid nanoparticles (SLN) for additional layer of protection to ensure better absorption. Although there are still some challenges that need to be considered including toxicity, error in absorption rate, and other side effects, by overcoming these issues we will be able to focus on the future applications of such a capable drug delivery method.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abet V, Filace F, Recio J, Alvarez-Builla J, Burgos C. Review article: prodrug approach: an overview of recent cases. Eur J Med Chem. 2017;127:810–27. https://doi.org/10.1016/j.ejmech.2016.10.061.
Barot M, Bagui M, Gokulgandhi MR, Mitra AK. Prodrug strategies in ocular drug delivery. Med Chem (Shariqah (United Arab Emirates)). 2012;8(4):753–68.
Seyfoddin A, Shaw J, Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv. 2010;17(7):467–89.
Talluri RS, Samanta SK, Gaudana R, Mitra AK. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir. Int J Pharm. 2008;361(1–2):118–24. https://doi.org/10.1016/j.ijpharm.2008.05.024.
Wang Z, Pal D, Mitra AK. Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir. J Pharm Sci. 2012;101:3199–213. https://doi.org/10.1002/jps.23193.
Yang X, Shah SJ, Wang Z, Agrahari V, Pal D, Mitra AK. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Drug Deliv. 2015;23(7):2399–409. https://doi.org/10.3109/10717544.2014.996833.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Patil, S., Pathak, N., Pathak, Y.V. (2018). Stereoisomeric Dipeptide Prodrug Approach for Retina and Posterior Segment Disease. In: Patel, J., Sutariya, V., Kanwar, J., Pathak, Y. (eds) Drug Delivery for the Retina and Posterior Segment Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-95807-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-95807-1_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95806-4
Online ISBN: 978-3-319-95807-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)